Prognostication of HCC under sorafenib: Is it always possible?

Liver Int. 2020 May;40(5):1241-1243. doi: 10.1111/liv.14294. Epub 2019 Nov 26.

Authors

Xavier Adhoute¹, Guillaume Pénaranda², Jean-Luc Raoul³, Marc Bourlière¹

Affiliations

¹ Department of Gastroenterology and Hepatology, Hôpital Saint-Joseph Marseille, Marseille, France.
² AlphaBio Laboratory Marseille, Marseille, France.
³ Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes, Nantes, France.

PMID: 31705837
DOI: 10.1111/liv.14294

No abstract available

Keywords: hepatocellular carcinoma; prognosis; sorafenib.

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Cell Line, Tumor
Drug Resistance, Neoplasm
Humans
Liver Neoplasms*
Prognosis
Sorafenib

Substances

Sorafenib